Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Nuvectis Pharma (NVCT) Institutional Ownership

Nuvectis Pharma logo
$10.94 +0.31 (+2.92%)
Closing price 04:00 PM Eastern
Extended Trading
$10.93 -0.01 (-0.09%)
As of 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Nuvectis Pharma (NASDAQ:NVCT)

Current
Institutional Ownership
Percentage
96.77%
Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$5.76M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$503.91K
Get NVCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

NVCT Institutional Buying and Selling by Quarter

Nuvectis Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE14,847$115K0.0%+10.2%0.056%
5/5/2026 Bank of New York Mellon Corp30,315$234K0.0%-4.2%0.110%
2/16/2026 Occam Crest Management LP380,000$2.87M2.0%+31.0%1.435%
2/16/2026 Barclays PLC24,185$183K0.0%+31.3%0.091%
2/13/2026 Charles Schwab Investment Management Inc.44,022$332K0.0%+15.9%0.172%
2/13/2026 State Street Corp154,666$1.17M0.0%+13.1%0.604%
2/13/2026 Wells Fargo & Company MN16,929$128K0.0%+114.1%0.066%
2/12/2026CIBC Private Wealth Group LLC14,574$110K0.0%N/A0.057%
2/11/2026 Deutsche Bank AG12,672$96K0.0%+3,671.4%0.049%
2/10/2026 Goldman Sachs Group Inc.26,503$200K0.0%-41.3%0.103%
2/9/2026 Geode Capital Management LLC364,024$2.75M0.0%+11.8%1.421%
2/2/2026 Oppenheimer & Co. Inc.73,566$555K0.0%+6.5%0.287%
1/23/2026 Iridian Asset Management LLC CT586,320$4.43M1.6%+44.5%2.289%
1/7/2026 Baldwin Wealth Partners LLC MA389,625$2.94M0.2%+11.2%1.521%
11/10/2025 Avalon Trust Co10,000$60K0.0%N/A0.039%
11/7/2025 GSA Capital Partners LLP23,450$141K0.0%-40.1%0.092%
11/7/2025Vanguard Group Inc.698,708$4.21M0.0%+4.8%2.728%
11/3/2025 New York State Common Retirement Fund5,000$30K0.0%-61.5%0.020%
10/24/2025 Iridian Asset Management LLC CT405,621$2.44M1.0%+8.8%1.593%
8/19/2025 Marex Group plc15,000$112K0.0%N/A0.059%
8/15/2025 Bank of America Corp DE8,565$64K0.0%+417.2%0.034%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,029$53K0.0%N/A0.028%
8/13/2025 Marshall Wace LLP63,613$475K0.0%+63.6%0.250%
8/13/2025 New York State Common Retirement Fund13,000$97K0.0%N/A0.051%
8/12/2025 JPMorgan Chase & Co.6,263$47K0.0%+3,398.9%0.025%
8/8/2025 Police & Firemen s Retirement System of New Jersey3,785$28K0.0%N/A0.018%
8/8/2025 Austin Wealth Management LLC20,125$140K0.0%-50.0%0.096%
8/8/2025 Geode Capital Management LLC285,332$2.13M0.0%+110.8%1.366%
7/24/2025 Baldwin Wealth Partners LLC MA350,461$2.62M0.2%-2.2%1.678%
6/27/2025 Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218%
5/19/2025Jane Street Group LLC42,299$413K0.0%N/A0.202%
5/16/2025Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218%
5/15/2025OMERS ADMINISTRATION Corp32,882$321K0.0%N/A0.139%
5/1/2025Austin Wealth Management LLC40,250$393K0.1%N/A0.172%
4/30/2025Iridian Asset Management LLC CT253,972$2.48M0.8%N/A1.086%
4/23/2025Oppenheimer & Co. Inc.41,000$401K0.0%+64.0%0.175%
4/14/2025Baldwin Wealth Partners LLC MA358,461$3.50M0.2%+0.7%1.532%
4/11/2025Blue Zone Wealth Advisors LLC10,424$102K0.0%N/A0.045%
2/17/2025Squarepoint Ops LLC19,071$103K0.0%N/A0.099%
2/17/2025Two Sigma Investments LP18,570$100K0.0%-30.7%0.096%
I was right about SpaceX (Ad)

Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel

See how to claim your stake in SpaceX before the public can
2/17/2025Millennium Management LLC29,698$161K0.0%-56.6%0.154%
2/17/2025Cubist Systematic Strategies LLC6,294$34K0.0%N/A0.033%
2/14/2025Northern Trust Corp25,725$139K0.0%+68.7%0.133%
2/13/2025Marshall Wace LLP124,571$674K0.0%+191.0%0.645%
2/12/2025Edmond DE Rothschild Holding S.A.15,170$82K0.0%-20.9%0.079%
2/12/2025Baxter Bros Inc.15,000$81K0.0%+20.0%0.078%
2/5/2025Oppenheimer & Co. Inc.25,000$135K0.0%N/A0.129%
1/30/2025Nations Financial Group Inc. IA ADV13,500$73K0.0%+35.0%0.070%
1/28/2025Forbes J M & Co. LLP59,000$319K0.0%+21.9%0.305%
1/22/2025Baldwin Wealth Partners LLC MA355,961$1.93M0.1%+104.4%1.842%
11/16/2024Geode Capital Management LLC79,716$501K0.0%+49.8%0.413%
11/5/2024GSA Capital Partners LLP50,129$315K0.0%+3.7%0.269%
11/5/2024Nations Financial Group Inc. IA ADV10,000$63K0.0%N/A0.054%
10/25/2024Iridian Asset Management LLC CT55,380$348K0.1%N/A0.297%
9/16/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050%
8/15/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050%
8/14/2024Marshall Wace LLP33,868$214K0.0%-32.4%0.185%
8/9/2024Renaissance Technologies LLC74,500$472K0.0%+20.7%0.406%
7/16/2024Baxter Bros Inc.12,500$79K0.0%N/A0.068%
7/12/2024Baldwin Brothers LLC MA168,630$1.07M0.1%+9.4%0.918%
5/10/2024Vanguard Group Inc.298,800$2.45M0.0%+1.5%1.626%
4/18/2024Blue Zone Wealth Advisors LLC14,350$118K0.0%N/A0.081%
2/12/2024Edmond DE Rothschild Holding S.A.19,170$160K0.0%N/A0.111%
1/30/2024Strs Ohio6,200$51K0.0%+59.0%0.036%
1/8/2024Baldwin Brothers LLC MA142,040$1.19M0.1%+22.0%0.820%
11/2/2023Forbes J M & Co. LLP34,000$438K0.1%-49.3%0.197%
10/26/2023Strs Ohio3,900$50K0.0%+178.6%0.023%
10/10/2023Baldwin Brothers LLC MA116,380$1.50M0.1%+29.2%0.675%
8/10/2023Hollencrest Capital Management3,040$49K0.0%N/A0.019%
8/4/2023American International Group Inc.3,298$53K0.0%N/A0.021%
8/3/2023Forbes J M & Co. LLP67,000$1.07M0.1%N/A0.418%
8/2/2023Bank of Montreal Can11,012$200K0.0%N/A0.069%
7/14/2023Baldwin Brothers LLC MA90,061$1.44M0.1%-37.4%0.563%
5/11/2023Edmond DE Rothschild Holding S.A.24,570$322K0.0%N/A0.167%
4/21/2023Baldwin Brothers LLC MA143,800$1.89M0.2%+7.9%0.975%
11/4/2022Ronit Capital LLP562,547$3.99M5.4%+34.2%3.843%
10/14/2022Baldwin Brothers LLC MA133,000$943K0.1%+9.9%0.908%
8/4/2022Ronit Capital LLP419,282$4.70M6.7%-23.8%3.297%
7/18/2022Baldwin Brothers LLC MA121,000$1.36M0.2%N/A0.951%
5/11/2022Ronit Capital LLP550,000$4.08M5.1%N/A4.325%


NVCT Institutional Ownership - Frequently Asked Questions

During the previous two years, 39 institutional investors and hedge funds held shares of Nuvectis Pharma. The most heavily invested institutionals were Iridian Asset Management LLC CT ($4.43M), Vanguard Group Inc. ($4.21M), Baldwin Wealth Partners LLC MA ($2.94M), Occam Crest Management LP ($2.87M), Geode Capital Management LLC ($2.75M), State Street Corp ($1.17M), and Baldwin Brothers LLC MA ($1.07M).Learn more on Nuvectis Pharma's institutional investors.

96.77% of Nuvectis Pharma's stock is owned by institutional investors. Learn more on NVCT's institutional investor holdings.

Of the 35 institutional investors that purchased Nuvectis Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Iridian Asset Management LLC CT ($522.96K), Baldwin Wealth Partners LLC MA ($223.50K), Geode Capital Management LLC ($214.78K), Marshall Wace LLP ($106.50K), Goldman Sachs Group Inc. ($91.22K), Occam Crest Management LP ($90K), and Oppenheimer & Co. Inc. ($45.50K).

Institutional investors have bought a total of 766,673 shares in the last 24 months. This purchase volume represents approximately $5.76M in transactions.

The following institutional investors have sold Nuvectis Pharma stock in the last 24 months: Austin Wealth Management LLC ($20.13K), Goldman Sachs Group Inc. ($18.66K), GSA Capital Partners LLP ($15.71K), New York State Common Retirement Fund ($8K), Baldwin Wealth Partners LLC MA ($8K), and Bank of New York Mellon Corp ($1.32K).

Institutional investors have sold a total of 71,815 shares in the last 24 months. This volume of shares sold represents approximately $503.91K in transactions.



This page (NASDAQ:NVCT) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners